caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1902995558

Jayesh Mehta

Pulmonary DiseaseNanuet, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jayesh Mehta's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 93 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
GOOD SAMARITAN HOSPITAL OF SUFFERN2661,248
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
102473
Steven Reichard
Diagnostic Radiology · Newburgh, NY
96372
MONTEFIORE NYACK HOSPITAL93385
NPI 132601740192334
Scott Luchs
Diagnostic Radiology · Suffern, NY
81289
Sibin Thachet
Diagnostic Radiology · Boston, MA
66185
Douglas Hertford
Diagnostic Radiology · New York, NY
65200
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
61239
NPI 122505759950211
Mohammed Taoudi Benchekroun
Internal Medicine · Royal Oak, MI
41122
SCHECHTER, ANDREW41139
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,086
Unique beneficiaries
—
Total services
2,190
Distinct HCPCS
13
Medicare payment
$202K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 811 Pulmonary Disease providers in NY — top quintile (cohort median 790).
PRESCRIBING · PART D · 2024
Total Rx claims
3,473
Beneficiaries
—
Total drug cost
$861K
Distinct drugs
45
Brand share
52.5%
Top prescribed drugs
Albuterol Sulfate515 claims
Prednisone433 claims
Montelukast Sodium355 claims
Fluticasone/Vilanterol342 claims
Fluticasone/Umeclidin/Vilanter312 claims
QUALITY · MIPS · 2024
Final MIPS score
96.7
Quality
87.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
92.0
Payment adjustment
0.91%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.